Howard Rubin Biography and Net Worth

Director of Trupanion

Howard Rubin serves as Independent Director of the Company., since March 2010. Mr. Rubin currently serves on the Dean’s Advisory Board for the College of Veterinary Medicine at Western University of Health Sciences, the Chief Executive Officer Advisory Committee of the Western Veterinary Conference and the American Veterinary Medical Association Insurance Trust Governance Task Force. Mr. Rubin previously served as our Chief Operating Officer from March 2010 to May 2014, and as our Secretary from July 2012 to August 2013. Mr. Rubin founded and served as Chief Executive Officer at BrightHeart Veterinary Centers, a company operating specialty and emergency veterinary hospitals, from November 2007 to October 2009 and as the Chief Executive Officer of the National Commission on Veterinary Economic Issues, a non-profit association supporting the animal health and veterinary industry, from January 2001 to October 2007. Previously, he served as the Chief Executive Officer of Cardiopet, Inc. and as a Divisional Vice President of IDEXX Laboratories, Inc. Mr. Rubin also founded the Veterinary Referral Centre, a comprehensive, multi-specialty veterinary hospital. Mr. Rubin holds an M.B.A. from Washington University in St. Louis’ Olin Business School and a B.A. from Ohio Wesleyan University.

What is Howard E. Rubin's net worth?: The estimated net worth of Howard E. Rubin is at least $11.56 million as of February 28th, 2023. Mr. Rubin owns 227,855 shares of Trupanion stock worth more than $11,559,084 as of December 22nd. This net worth evaluation does not reflect any other investments that Mr. Rubin may own. Learn More about Howard E. Rubin's net worth.
How do I contact Howard E. Rubin?: The corporate mailing address for Mr. Rubin and other Trupanion executives is 6100 4TH AVENUE SOUTH SUITE 200, SEATTLE WA, 98108. Trupanion can also be reached via phone at (855) 727-9079 and via email at [email protected]. Learn More on Howard E. Rubin's contact information.
Has Howard E. Rubin been buying or selling shares of Trupanion?: Howard E. Rubin has not been actively trading shares of Trupanion during the last ninety days. Most recently, Howard E. Rubin sold 3,500 shares of the business's stock in a transaction on Tuesday, February 28th. The shares were sold at an average price of $58.85, for a transaction totalling $205,975.00. Following the completion of the sale, the director now directly owns 227,855 shares of the company's stock, valued at $13,409,266.75. Learn More on Howard E. Rubin's trading history.
Who are Trupanion's active insiders?: Trupanion's insider roster includes Asher Bearman (Insider), Michael Doak (Director), Robin Ferracone (Director), Gavin Friedman (EVP), Dan Levitan (Director), Murray Low (Director), Tricia Plouf (CFO), Darryl Rawlings (Founder, CEO & Chair of the Board), Howard Rubin (Director), and Margaret Tooth (Insider). Learn More on Trupanion's active insiders.
Are insiders buying or selling shares of Trupanion?: During the last year, Trupanion insiders bought shares 1 times. They purchased a total of 20,700 shares worth more than $499,698.00. During the last year, insiders at the financial services provider sold shares 12 times. They sold a total of 42,494 shares worth more than $2,062,305.04. The most recent insider tranaction occured on November, 29th when CFO Fawwad Qureshi sold 9,867 shares worth more than $523,740.36. Insiders at Trupanion own 5.5% of the company. Learn More about insider trades at Trupanion.
Information on this page was last updated on 11/29/2024.

Howard E. Rubin Insider Trading History at Trupanion

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
2/28/2023	Sell	3,500	$58.85	$205,975.00	227,855
11/12/2021	Sell	3,468	$125.49	$435,199.32
11/10/2021	Sell	1,532	$125.00	$191,500.00
11/5/2020	Sell	10,000	$91.26	$912,600.00	217,012
2/27/2019	Sell	26,043	$29.93	$779,466.99	122,368
2/25/2019	Sell	11,457	$30.05	$344,282.85	132,368
2/21/2019	Sell	2,500	$30.00	$75,000.00	143,825
2/14/2019	Sell	60,000	$29.03	$1,741,800.00	188,739
2/12/2019	Sell	17,586	$29.00	$509,994.00	188,739
11/26/2018	Sell	45,000	$27.02	$1,215,900.00	230,993
11/23/2018	Sell	7,376	$27.02	$199,299.52	230,993
11/21/2018	Sell	25,279	$27.01	$682,785.79	230,993
10/2/2017	Sell	100,000	$25.90	$2,590,000.00
11/30/2016	Sell	28,751	$17.00	$488,767.00	10,352
11/23/2016	Sell	21,249	$17.01	$361,445.49	41,294
11/22/2016	Sell	8,706	$17.00	$148,002.00	41,294
10/3/2016	Sell	75,000	$16.56	$1,242,000.00	100,000
8/30/2016	Sell	21,379	$14.95	$319,616.05	146,579
8/29/2016	Sell	1,020	$14.98	$15,279.60	146,579
8/26/2016	Sell	17,556	$14.93	$262,111.08	162,399
8/23/2016	Sell	200	$14.91	$2,982.00	168,055
8/22/2016	Sell	4,369	$14.94	$65,272.86	168,055
8/16/2016	Sell	11,082	$15.00	$166,230.00	169,524
8/11/2016	Sell	19,520	$15.07	$294,166.40	185,126
8/10/2016	Sell	33,574	$15.00	$503,610.00	105,126
8/8/2016	Sell	16,300	$15.01	$244,663.00	110,000

Howard E. Rubin Buying and Selling Activity at Trupanion

Trupanion Company Overview

Trupanion, Inc., together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians. The company was formerly known as Vetinsurance International, Inc. changed its name to Trupanion, Inc. in 2013. Trupanion, Inc. was founded in 2000 and is headquartered in Seattle, Washington.

Today's Range

Now: $50.73

$48.00

$51.97

50 Day Range

MA: $52.92

$48.92

$56.01

2 Week Range

Now: $50.73

$19.69

$57.90

Volume

1,396,242 shs

Average Volume

669,195 shs

Market Capitalization

$2.15 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.6

Vladimir Lenin was right…

From Porter & Company | Ad

The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold $3 billion of Amazon… it’s why Nvidia’s CEO just sold $713 million... and it’s why Zuckerberg just sold $1.3 billion in Meta stock. The financial establishment doesn’t want you to know about this… but a controversial new documentary just pulled back the curtain and exposed what’s really going on. It’s called The Final Frontier.

Including the name of the #1 company to buy.